Average annual oncology novel active substance launches (multi-year total) vs Sales growth at constant exchange rates

Average annual oncology novel active substance launches (multi-year total) and Sales growth at constant exchange rates worldwide, compared over time.

Change the pair

Compare different indicators

The series

Over time

Global, spaced by time . Different units, drawn on separate scales and clipped to the years both series publish — earlier history stays on each indicator's own page. Read the values, not the heights.

Average annual oncology novel active substance launches (multi-year total)

Unit: count · 2 observations

Line chart
Average annual oncology novel active substance launches (multi-year total)Average annual oncology novel active substance launches (multi-year total). 2 observations from 2015–2019 to 2020–2024, ranging from 16 to 26. Latest value 26 (2020–2024). 0 5 10 15 20 25 30 2015 2017 2019 2021 2023 2025 16 26
Average annual oncology novel active substance launches (multi-year total)Average annual oncology novel active substance launches (multi-year total). 2 observations from 2015–2019 to 2020–2024, ranging from 16 to 26. Latest value 26 (2020–2024). 0 10 20 30 2015 2017 2019 2021 2023 2025 16 26
Average annual oncology novel active substance launches (multi-year total)Average annual oncology novel active substance launches (multi-year total). 2 observations from 2015–2019 to 2020–2024, ranging from 16 to 26. Latest value 26 (2020–2024). 0 10 20 30 2015 2017 2019 2021 2023 2025 16 26
View the underlying data
Average annual oncology novel active substance launches (multi-year total)
Period Type Value
2015–2019 Actual 16
2020–2024 Actual 26
Source: IQVIA · CC BY 4.0 · Full series

Sales growth at constant exchange rates

Unit: % · 2 observations

Line chart
Sales growth at constant exchange ratesSales growth at constant exchange rates. 2 observations from Q1 2026 to Q2 2026, ranging from 3% to 17.8%. Latest value 17.8% (Q2 2026). % 0 5 10 15 20 2015 2017 2019 2021 2023 2025 3% 18%
Sales growth at constant exchange ratesSales growth at constant exchange rates. 2 observations from Q1 2026 to Q2 2026, ranging from 3% to 17.8%. Latest value 17.8% (Q2 2026). % 0 5 10 15 20 2015 2017 2019 2021 2023 2025 3% 18%
Sales growth at constant exchange ratesSales growth at constant exchange rates. 2 observations from Q1 2026 to Q2 2026, ranging from 3% to 17.8%. Latest value 17.8% (Q2 2026). % 0 5 10 15 20 2015 2017 2019 2021 2023 2025 3% 18%
View the underlying data
Sales growth at constant exchange rates
Period Type Value
Q1 2026 Actual 3%
Q2 2026 Actual 17.8%
Source: Roche, Sanofi · CC BY 4.0 · Full series

Provenance

Where these numbers come from

Average annual oncology novel active substance launches (multi-year total)

Average annual count of oncology novel active substances launched across a multi-year period.

2 observations in Global · source organisations: IQVIA

Sales growth at constant exchange rates

Percentage change in sales calculated at constant exchange rates over the specified period.

2 observations in Global · source organisations: Roche, Sanofi

Data published under CC BY 4.0. Series A as JSON · Series B as JSON

Keep exploring

Related